TRADING UPDATES: Catenai renews contract; Angus sees production uplift
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.225p on 01-05-2026 at 15:50:09 |
|---|---|
| Change | -0.005p -2.22% |
| Buy | 0.23p |
| Sell | 0.21p |
| Last Trade: | Sell 250,000.00 at 0.2125p |
| Day's Volume: | 5,495,984 |
| Last Close: | 0.22p |
| Open: | 0.225p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.22p - 0.225p |
| 52wk Range: | 0.18p - 0.286p |
| Market Capitalisation: | £4.73m |
| VWAP: | 0.220813p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 250,000 | 0.2125p | Ordinary |
16:14:15 - 01-May-26 |
| Buy* | 1,000,000 | 0.224p | Ordinary |
14:33:26 - 01-May-26 |
| Buy* | 535,714 | 0.224p | Ordinary |
14:02:17 - 01-May-26 |
| Buy* | 169,642 | 0.224p | Ordinary |
13:58:29 - 01-May-26 |
| Buy* | 178,571 | 0.224p | Ordinary |
13:57:16 - 01-May-26 |
| Sell* | 1,000 | 0.2125p | Ordinary |
13:15:15 - 01-May-26 |
| Buy* | 200,000 | 0.224p | Ordinary |
12:31:26 - 01-May-26 |
| Sell* | 1,000,000 | 0.21p | Ordinary |
11:44:05 - 01-May-26 |
| Buy* | 1,500,000 | 0.2248p | Ordinary |
11:28:57 - 01-May-26 |
| Buy* | 151,000 | 0.225p | Ordinary |
11:27:57 - 01-May-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |